awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41694198-7311A513-323E-4265-8E9E-823005C5F65C
Q41694198-7311A513-323E-4265-8E9E-823005C5F65C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41694198-7311A513-323E-4265-8E9E-823005C5F65C
Emerging drugs and combinations to treat multiple myeloma.
P2860
Q41694198-7311A513-323E-4265-8E9E-823005C5F65C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41694198-7311A513-323E-4265-8E9E-823005C5F65C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
615c811e1f40bbd2941d1ea861fbaaf4701eb93a
P2860
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma